Ingenia Therapeutics (Reg.S) is listed on the KOSDAQ under the code 950260. This page gathers its daily price history, filed financial statements, dividends and downside risk measures on one screen, each with the conditions and the date it was computed on, and the guide explains what each measure does and does not say.
Ingenia Therapeutics (Reg.S)
Price chart
The conditions for computing a value are not met over this window, which happens when the listing is short, turnover is thin, or halts are frequent.
Characteristic line
No window of this issue can carry a characteristic line yet.
Each point is one period's index excess return and issue excess return, and the line is the regression fitted to those points. The risk-free rate is the certificate of deposit rate.
- Beta summarizes by regression how far the issue's return moved together with the KOSPI200 or KOSDAQ150 index return, and the index is only a stand-in for the whole market.
- The intercept is the average excess return the index does not explain, and when the interval shown beside it contains zero it cannot be told apart from zero.
- Beta and the intercept are computed from the sample of the chosen window and frequency and are not values for the period ahead.
- At the daily frequency a beta corrected for differences in trading times is shown alongside, and the gap between the two shows how much later than the index the issue's trades are reflected.
Financials
Filed accounts mapped onto a standard chart, with the filed figures preserved. The fiscal calendar and the reporting currency are left as the company filed them, so this will not agree to the last digit with a commercial screen.
Other issues on the same market
Neighbours in the market capitalisation order.